ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$0.46
+0.00 (+0.54%)
Open$0.50
Previous Close$0.46
Day High$0.55
Day Low$0.46
52W High$3.42
52W Low$0.30
Volume—
Avg Volume3.2K
Market Cap18.86M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+10,708.6% upside
Current
$0.46
$0.46
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.41M | 5.09M | 4.82M |
| Net Income | 1.02M | 757.9K | 675.0K |
| Profit Margin | 18.8% | 14.9% | 14.0% |
| EBITDA | 1.84M | 1.51M | 1.49M |
| Free Cash Flow | 747.3K | 835.9K | 744.4K |
| Rev Growth | +9.4% | +17.9% | +10.5% |
| Debt/Equity | 0.83 | 0.81 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |